Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Got stage fright? A fellow-led initiative to improve cancer staging documentation.

View through CrossRef
310 Background: Accurate cancer staging is essential for estimating prognosis, guiding treatment, populating cancer registries, and assessing clinical trial eligibility. Hence, timely staging of new solid oncology patients (NSOP) is an ASCO QOPI priority. At our institution, baseline review of staging documentation revealed fellows staged only 47% of NSOP, generally as unstructured free text. During the 2017-18 academic year, our structured electronic medical record (EMR) staging tool (ST) was used in only 11% of NSOP. We used Quality Improvement (QI) methods to improve structured EMR staging documentation rates of NSOP seen by fellows during the 2018-19 academic year. Methods: A fellow focus group identified poor integration of the EMR ST as root cause of our low staging rates. We set a cumulative goal of 70% structured EMR staging of NSOP within 1 month of initial visit as our target (50% increase from baseline). We incorporated the EMR ST into our visit workflow and used promotional flyers and fellow orientation to introduce our QI initiative. Staging rates were tracked by EMR-generated reports. We used periodic emails and QI-specific boards to disseminate progress among our oncology practices. Fellows were anonymously surveyed for feedback. Results: Over an 8-month period, the cumulative rate of NSOP staging by fellows increased from 47% to 70% (Table). Statistical process control analysis showed special-cause variation in July 2018 (low performance) and December 2018 (high performance). Fellow feedback highlighted the educational value of this QI intervention and identified incomplete workup as a barrier to staging. Conclusions: Our fellow-led QI intervention achieved our goal of leveraging an existing EMR tool to increase staging documentation. In addition, this QI intervention facilitated fellow education and use of data for clinical and research purposes. Future steps include ensuring sustainability and expansion into our hematology clinics. [Table: see text]
Title: Got stage fright? A fellow-led initiative to improve cancer staging documentation.
Description:
310 Background: Accurate cancer staging is essential for estimating prognosis, guiding treatment, populating cancer registries, and assessing clinical trial eligibility.
Hence, timely staging of new solid oncology patients (NSOP) is an ASCO QOPI priority.
At our institution, baseline review of staging documentation revealed fellows staged only 47% of NSOP, generally as unstructured free text.
During the 2017-18 academic year, our structured electronic medical record (EMR) staging tool (ST) was used in only 11% of NSOP.
We used Quality Improvement (QI) methods to improve structured EMR staging documentation rates of NSOP seen by fellows during the 2018-19 academic year.
Methods: A fellow focus group identified poor integration of the EMR ST as root cause of our low staging rates.
We set a cumulative goal of 70% structured EMR staging of NSOP within 1 month of initial visit as our target (50% increase from baseline).
We incorporated the EMR ST into our visit workflow and used promotional flyers and fellow orientation to introduce our QI initiative.
Staging rates were tracked by EMR-generated reports.
We used periodic emails and QI-specific boards to disseminate progress among our oncology practices.
Fellows were anonymously surveyed for feedback.
Results: Over an 8-month period, the cumulative rate of NSOP staging by fellows increased from 47% to 70% (Table).
Statistical process control analysis showed special-cause variation in July 2018 (low performance) and December 2018 (high performance).
Fellow feedback highlighted the educational value of this QI intervention and identified incomplete workup as a barrier to staging.
Conclusions: Our fellow-led QI intervention achieved our goal of leveraging an existing EMR tool to increase staging documentation.
In addition, this QI intervention facilitated fellow education and use of data for clinical and research purposes.
Future steps include ensuring sustainability and expansion into our hematology clinics.
[Table: see text].

Related Results

Ethnomedicine and ethnobotany of fright, a Caribbean culture-bound psychiatric syndrome
Ethnomedicine and ethnobotany of fright, a Caribbean culture-bound psychiatric syndrome
AbstractBackground"Fright" is an English-speaking Caribbean idiom for an illness, or ethnomedical syndrome, of persistent distress. A parallel ethnopsychiatric idiom exists in the ...
COMPARISON OF OPEN VS. MINIMALLY INVASIVE SURGICAL STAGING IN EARLY-STAGE OVARIAN CANCER
COMPARISON OF OPEN VS. MINIMALLY INVASIVE SURGICAL STAGING IN EARLY-STAGE OVARIAN CANCER
Background: Early-stage ovarian cancer is a critical area of study, where accurate staging plays a vital role in determining prognosis and treatment strategies. Surgical staging is...
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Predictors of False-Negative Axillary FNA Among Breast Cancer Patients: A Cross-Sectional Study
Abstract Introduction Fine-needle aspiration (FNA) is commonly used to investigate lymphadenopathy of suspected metastatic origin. The current study aims to find the association be...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

Back to Top